Your session is about to expire
← Back to Search
Depemokimab for Asthma
Study Summary
This trial compares how safe and effective a drug is when given via a needleless device or an autoinjector.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- You have had serious allergies or intolerances to certain medications or biological treatments in the past.You currently have or recently had a contagious illness.You have any health condition that could affect how your body absorbs, processes, or eliminates medications, or that could interfere with the study results.
- Group 1: Participants receiving depemokimab via a SSD
- Group 2: Participants receiving depemokimab via an autoinjector
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does the age limitation for this experiment include seniors above seventy-five years old?
"Individuals aged 18 to 50 are eligible for this medical trial. There are 117 other studies targeting minors and 193 specifically aimed at seniors."
What potential risk factors exist for individuals taking depemokimab via a subcutaneous delivery system?
"The safety of depemokimab administered using a SSD has only been tested in limited contexts, so it received an assessment score of 1."
What is the current enrollment for this clinical trial?
"Affirmative. According to clinicaltrials.gov, this trial was first announced on December 16th 2022 and is currently recruiting patients. The study requires a total of 140 participants from 3 different sites."
Are applications for participants currently being accepted by this research?
"That is correct. According to clinicaltrials.gov, this medical study, which began on December 16th 2022, currently has a call for volunteers. A total of 140 patients must be recruited from 3 distinct research centres."
Are there certain prerequisites for participating in this experiment?
"This research initiative seeks to recruit 140 participants, aged 18-50 and suffering from asthma. Other criteria include being medically healthy as confirmed by lab tests, physical exams, vital signs, EKG's etc., having a minimum body weight of 50 kilograms (110 Ibs) and BMI between 19-30 kg/m^2 , female patients of childbearing age must use highly effective contraception methods, and all study subjects must be willing to provide informed consent."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger